Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC
Clinical trial NCT03813394 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03813394
- Sponsor
- National University Hospital, Singapore
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2024-07-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.